While, naturally, there are outliers—up and down—the broad consensus among restaurant chains is the consumer remains ...

RUNNING HAS ALWAYS BEEN AMONG THE SIMPLEST of the ways we punish ourselves in the name of fitness. It requires no gym membership, no ClassPass, minimal strategy aside from putting one foot in front of ...

Indian equities closed higher on Wednesday, with the Sensex and Nifty extending gains for a third straight session after the ...

Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.

Novo Nordisk said that patients taking a pill form of Wegovy in a clinical trial lost about as much weight as those who get the shot version, fueling new optimism that oral GLP-1 drugs could expand an ...

Bank of England Chief Economist Huw Pill said on Wednesday that central bankers should adopt what he described as a ...

Charlotte Lee does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

A GLP-1 drug called orforglipron—taken in pill form once a day—has been shown to help with "significant" weight loss in people with obesity. In a multinational trial of around 3,000 adults, a 72-week ...

A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and Zepbound are racing to launch once-daily oral versions that may help people ...

Treasuries gained after a reading on inflation came in as expected, leaving the Federal Reserve on track to continue cutting interest rates next month. The gains pushed down yields by about one basis ...

This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh ...